However, in a mouse model of breast cancer, IL-15Rα+TAM releases IL-15Rc (the IL-15/IL-15Rα complex) to reduce the expression of chemokine CX3CL1 in tumor cells, thereby reducing recruitment to CD8+T cells [61]. Here, IL15RA is linked to breast carcinoma.